Category - F. Hoffmann-La Roche Inc.

• Developer takes on Clifton over mandate
• Deal signals AI startups can thrive here
• Roche buys AI startup focused on digital pathology for $750m
• Novartis, Roche near deal with US on drug pricing
• Novartis, Roche near deal with US on drug pricing
• Manifold Bio in deal with giant Roche
• Adding 650 jobs, Roche will invest $550 million in Indy for glucose monitors
• Roche could increase U.S. output ‘overnight,’ CEO says amid tariff wars
• Roche picks IN for new facility
• Roche to invest $50B in U.S. to avoid tariffs
• Roche to invest $50B in U.S. to avoid tariffs
• Roche to invest $50B in U.S. to avoid tariffs
• ROCHE TO INVEST $ 50 BILLION IN PHARMA, DIAGNOSTIC SINUS
• Swiss firm Roche plans $50 billion investment in U.S.
• Roche plans $50B manufactur­ing expansion in U.S.
• Roche to invest $50B in U.S. to avoid tariffs
• Roche to open innovation center in Allston
• Roche Bobois Slightly Misses 2024 Revenue Guidance
• Tucson company marks 40 years of cancer testing
• Roche strong
• La Roche-Posay Set Sights High Before Turning 50
• Roche family is selling Roche Bros. markets
• Roche discloses patient death in Alzheimer’s trial
• Roche Bobois RBO Cuts Sales Guidance
• Roche Bobois Sees H1 Sales Fall; Remains Confident on 2024
• Roche Bobois Sees Improved ‘ 25 Following Strategic China Step
• Roche Bobois Readies to Take on China
• Roche Bobois Sees 2024 Sales Matching 2023
• Alnylam, Roche experiment­al high blood pressure drug show promise
• Roche subsidiary Foundation Medicine gets new head
• Roche to buy developer of weight-loss drugs
• Roche to buy maker of bowel disease drug
• Roche to buy maker of bowel disease drug
• Roche, Alnylam sign deal for $2.8b
• UPMC spinout to form partnershi­p with Roche